AbbVie Stock Target Price and Analyst Consensus

ABBV Stock  USD 178.49  0.61  0.34%   
The current analyst and expert consensus on AbbVie is Buy with 8 buy recommendations. The current projected AbbVie target price consensus is 160.21, with 30 analyst opinions. The most common way AbbVie Inc analysts use to provide public buy-or-sell recommendation is financial statements analysis. They also talk to AbbVie executives, vendors, and/or customers. AbbVie buy-or-sell recommendation module provides average expert sentiment on the projected AbbVie Inc target price to derive its highest and lowest estimates based on target price estimated volatility of 0.0. Check out Macroaxis Advice on AbbVie to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
Lowest Forecast
145.79
Highest Forecast
177.83
Target Price
160.21
Gross Profit is likely to drop to about 25.2 B in 2024. Pretax Profit Margin is likely to drop to 0.11 in 2024. At this time, AbbVie's Deferred Long Term Liabilities is fairly stable compared to the past year.
  
It's important to approach AbbVie's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

AbbVie Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. AbbVie target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. AbbVie's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   30  Buy
Most AbbVie analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand AbbVie stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of AbbVie Inc, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

AbbVie Target Price Projection

AbbVie's current and average target prices are 178.49 and 160.21, respectively. The current price of AbbVie is the price at which AbbVie Inc is currently trading. On the other hand, AbbVie's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

AbbVie Market Quote on 19th of March 2024

Low Price177.57Odds
High Price179.88Odds

178.49

Target Price

Analyst Consensus On AbbVie Target Price

Low Estimate145.79Odds
High Estimate177.83Odds

160.21

Historical Lowest Forecast  145.79 Target Price  160.21 Highest Forecast  177.83
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on AbbVie Inc and the information provided on this page.

AbbVie Analyst Ratings

AbbVie's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about AbbVie stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of AbbVie's financials, market performance, and future outlook by experienced professionals. AbbVie's historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize AbbVie price targets

AbbVie's stock target price is an estimate of its future price, usually made by analysts. Using AbbVie's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at AbbVie's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if AbbVie's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional AbbVie Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of AbbVie is a key component of AbbVie valuation and have some predictive power on the future returns of a AbbVie.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of AbbVie's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of AbbVie in the context of predictive analytics.
Hype
Prediction
LowEstimatedHigh
177.90178.81179.72
Details
Intrinsic
Valuation
LowRealHigh
160.64181.70182.61
Details
Earnings
Estimates (0)
LowProjected EPSHigh
2.302.342.40
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as AbbVie. Your research has to be compared to or analyzed against AbbVie's peers to derive any actionable benefits. When done correctly, AbbVie's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in AbbVie Inc.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested over 500 shares
When determining whether AbbVie Inc is a strong investment it is important to analyze AbbVie's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact AbbVie's future performance. For an informed investment choice regarding AbbVie Stock, refer to the following important reports:
Check out Macroaxis Advice on AbbVie to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
Note that the AbbVie Inc information on this page should be used as a complementary analysis to other AbbVie's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Complementary Tools for AbbVie Stock analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Global Correlations
Find global opportunities by holding instruments from different markets
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
The data published in AbbVie's official financial statements usually reflect AbbVie's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of AbbVie Inc. For example, before you start analyzing numbers published by AbbVie accountants, it's critical to develop an understanding of what AbbVie's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of AbbVie's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AbbVie's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in AbbVie's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of AbbVie Inc. Please utilize our Beneish M Score to check the likelihood of AbbVie's management manipulating its earnings.